ACIU compared with XOMA: revenue, margins and what each company keeps, and the suppliers and customers both name

ACIUAC Immune SA

Mkt capRevenueRevenue

XOMAXOMA Royalty Corp

Mkt capRevenueRevenue

Compare

ACIUAC Immune SA

XOMAXOMA Royalty Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ACIU 4

LLYEli Lillycustomer

JNJJanssen Pharmaceuticalscustomer

LNTHLantheuscustomer

TAKTakeda Pharmaceuticals USAcustomer

Shared 0

No shared counterparties.

Only XOMA 5

RZLTRezolutecustomer

OWLBlue Owl Capitalsupplier

OGNOrganoncustomer

NVSNovartiscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

1 more · XOMA chain ›

ACIUAC Immune SA

2.05· pre 2.10· delayed

Mkt cap$222.9MRevenue—Revenue—

XOMAXOMA Royalty Corp

39.97· pre 39.35· delayed

Pre-marketNov 2 '26delayed

Mkt cap$503.8MRevenue$12MQ1 FY26Revenue$52MFY25

Compare

Pre-marketNov 2 '26delayed

ACIUAC Immune SA

XOMAXOMA Royalty Corp

2.05pre 2.10delayed

Price

39.97pre 39.35delayed

$222.9M

Mkt cap

$503.8M

—

Revenue

$12MQ1 FY26

—

Revenue

$52MFY25

ACIU2.05vsXOMA39.97Pre-marketNov 2 '26delayed